U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214571) titled 'A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease' on Oct. 08.
Brief Summary: The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Respiratory Syncytial Virus Infections
Intervention:
DRUG: S-337395
S-337395 will be administered per schedule specified i...